全文获取类型
收费全文 | 4597篇 |
免费 | 334篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 127篇 |
妇产科学 | 104篇 |
基础医学 | 677篇 |
口腔科学 | 53篇 |
临床医学 | 469篇 |
内科学 | 1207篇 |
皮肤病学 | 62篇 |
神经病学 | 379篇 |
特种医学 | 122篇 |
外国民族医学 | 1篇 |
外科学 | 859篇 |
综合类 | 7篇 |
一般理论 | 2篇 |
预防医学 | 282篇 |
眼科学 | 94篇 |
药学 | 201篇 |
中国医学 | 3篇 |
肿瘤学 | 272篇 |
出版年
2023年 | 33篇 |
2022年 | 65篇 |
2021年 | 192篇 |
2020年 | 93篇 |
2019年 | 170篇 |
2018年 | 188篇 |
2017年 | 116篇 |
2016年 | 109篇 |
2015年 | 158篇 |
2014年 | 157篇 |
2013年 | 250篇 |
2012年 | 339篇 |
2011年 | 310篇 |
2010年 | 179篇 |
2009年 | 155篇 |
2008年 | 275篇 |
2007年 | 265篇 |
2006年 | 284篇 |
2005年 | 209篇 |
2004年 | 195篇 |
2003年 | 191篇 |
2002年 | 161篇 |
2001年 | 73篇 |
2000年 | 75篇 |
1999年 | 65篇 |
1998年 | 21篇 |
1997年 | 36篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 14篇 |
1992年 | 51篇 |
1991年 | 40篇 |
1990年 | 31篇 |
1989年 | 28篇 |
1988年 | 29篇 |
1987年 | 30篇 |
1986年 | 32篇 |
1985年 | 30篇 |
1984年 | 27篇 |
1983年 | 16篇 |
1981年 | 15篇 |
1979年 | 24篇 |
1978年 | 14篇 |
1977年 | 17篇 |
1975年 | 11篇 |
1974年 | 18篇 |
1973年 | 20篇 |
1972年 | 17篇 |
1971年 | 21篇 |
1969年 | 11篇 |
排序方式: 共有4959条查询结果,搜索用时 0 毫秒
31.
Pauline Vetter Arnaud G. LHuillier Maria F. Montalbano Fiona Pigny Isabella Eckerle Giulia Torriani Sylvia Rothenberger Florian Laubscher Samuel Cordey Laurent Kaiser Manuel Schibler 《Emerging infectious diseases》2021,27(2):658
We report 3 cases of Puumala virus infection in a family in Switzerland in January 2019. Clinical manifestations of the infection ranged from mild influenza-like illness to fatal disease. This cluster illustrates the wide range of clinical manifestations of Old World hantavirus infections and the challenge of diagnosing travel-related hemorrhagic fevers. 相似文献
32.
Camille Granger Paul Guedeney Camille Arnaud Soulef Guendouz Claire Cimadevilla Mathieu Kerneis Caroline Kerneis Michel Zeitouni Constance Verdonk Camille Legeai Guillaume Lebreton Pascal Leprince Eva Désiré Sabato Sorrentino Johanne Silvain Gilles Montalescot Fanny Hazan Shaida Varnous Richard Dorent 《Transplant international》2021,34(4):721-731
Available data on clinical presentation and mortality of coronavirus disease-2019 (COVID-19) in heart transplant (HT) recipients remain limited. We report a case series of laboratory-confirmed COVID-19 in 39 HT recipients from 3 French heart transplant centres (mean age 54.4 ± 14.8 years; 66.7% males). Hospital admission was required for 35 (89.7%) cases including 14/39 (35.9%) cases being admitted in intensive care unit. Immunosuppressive medications were reduced or discontinued in 74.4% of the patients. After a median follow-up of 54 (19–80) days, death and death or need for mechanical ventilation occurred in 25.6% and 33.3% of patients, respectively. Elevated C-reactive protein and lung involvement ≥50% on chest computed tomography (CT) at admission were associated with an increased risk of death or need for mechanical ventilation. Mortality rate from March to June in the entire 3-centre HT recipient cohort was 56% higher in 2020 compared to the time-matched 2019 cohort (2% vs. 1.28%, P = 0.15). In a meta-analysis including 4 studies, pre-existing diabetes mellitus (OR 3.60, 95% CI 1.43–9.06, I2 = 0%, P = 0.006) and chronic kidney disease stage III or higher (OR 3.79, 95% CI 1.39–10.31, I2 = 0%, P = 0.009) were associated with increased mortality. These findings highlight the aggressive clinical course of COVID-19 in HT recipients. 相似文献
33.
Sybille Rousseau Matthieu Peycelon Céline Grosos Valeska Bidault Anna Poupalou Garance Martin Éric Dobremez Luke Harper Claire Raquillet Alexis Arnaud Emmanuel Sapin Aurélien Scalabre Philippe Buisson Guillaume Levard Isabelle Pommepuy Maguelonne Pons Laurent Fourcade Quentin Ballouhey 《Journal of pediatric surgery》2021,56(2):332-336
IntroductionFibroepithelial polyps (FEP) of the lower urinary tract are relatively common in adults but rare in children, with fewer than 250 cases reported in the literature to date.ObjectiveThe aim of this study was to address the experience of FEP management in children.Study designA retrospective multicenter review was undertaken in children with defined FEP of the lower urinary tract managed between 2008 and 2018. The data at 18 pediatric surgery centers were collected. Their demographic, radiological, surgical, and pathological information were reviewed.ResultsA total of 33 children (26 boys; 7 girls) were treated for FEP of the lower urinary tract at 13 centers. The most common presentation was urinary outflow as hematuria (41%), acute urinary retention (25%), dysuria (19%), or urinary infections (28%). A prenatal diagnosis was made for three patients with hydronephrosis. Almost all of the children (94%) underwent ultrasound imaging of the urinary tract as the first diagnostic examination, 23 (70%) of them also either had an MRI (15%), cystourethrography (25%), computerized tomography (6%), or cystoscopy (45%). Two of these children (6%) had a biopsy prior to the surgery. The median preoperative delay was 7.52 (range: 1–48) months. Most of the patients were treated endoscopically, although four (12.1%) had open surgery and two (6.1%) had an additional incision for specimen extraction. The median hospital stay was 1.5 (range: 1–10) days. There were no recurrences and no complications after a median follow-up of 13 (range: 1–34) months.DiscussionThe main limitation of our study is the retrospective design, although it is the largest one for this pathology.ConclusionThis series supports sonography as the most suitable diagnosis tool before endoscopy to confirm the diagnosis and to perform the resection for most FEP in children. This report confirms the recognized benign nature in the absence of recurrences.Level of EvidenceLevel V. 相似文献
34.
Sofiane Allali MD Vincent Servois MD Arnaud Beddok MD Alain Fourquet MD Youlia Kirova MD 《The breast journal》2021,27(11):824-827
The COVID-19 caused by the SARS-CoV-2 coronavirus is at the origin of a global pandemic. This pandemic has prompted the current health system to reorganize and rethink the care offered by health establishments. We report the early toxicity in patients infected with COVID-19 treated at the same time for early-stage breast cancer (BC). This is a monocentric prospective study of patients treated in our hospital between March 2020 and June 2020 and were diagnosed with COVID-19 infection. The inclusion criteria were to be irradiated for early-stage BC and to have a positive COVID-19 diagnosis on a PCR test and/or a lung computed tomography (CT) scan and/or suggestive clinical symptoms. Radiotherapy (RT) consisted of breast or chest wall irradiation with or without lymph node irradiation, with protocols adapted to pandemic situation. The treatment-related toxicity was graded according to the CTCAE (version 4.03). All 350 patients treated for early-stage BC were studied. Of them, 16 were presented with clinical symptoms of COVID-19 infection and of them, 12 had clinical, CT scan, and PCR confirmation. This entire cohort of 12 pts with median age of 56 (42–72) underwent their RT. During the radiotherapy, there were 9 pts presented radiation dermatitis, 8 (66%) were grade 1 and one was (8%) grade 2. Two patients with lymph nodes irradiation presented esophagitis grade 2. This prospective COVID-19 cohort, treated for early-stage BC demonstrated an acceptable toxicity profile with few low-grade adverse events. Longer follow-up is needed to confirm these findings. 相似文献
35.
36.
Cedric Hirzel Arnaud G. L'Huillier Victor H. Ferreira Tina Marinelli Terrance Ku Matthew Ierullo Congrong Miao D. Scott Schmid Stephen Juvet Atul Humar Deepali Kumar 《American journal of transplantation》2021,21(6):2246-2253
Lung transplant recipients are at high risk for herpes zoster and preventive measures are a significant unmet need. We investigated the safety and immunogenicity of two doses of a recombinant zoster vaccine (RZV) in lung transplant recipients (≥50 years). We enrolled 50 patients of which 49 received at least one vaccine dose. Anti-glycoprotein E (gE) antibody levels (n = 43) increased significantly compared to baseline (median optical density [OD] 1.96; interquartile range [IQR]: 1.17–2.89) after the first (median OD 3.41, IQR 2.54–3.81, p < .0001) and second vaccine dose (median OD 3.63, IQR 3.39–3.86, p < .0001). gE-specific polyfunctional CD4+ T cell frequencies (n = 38) also increased from baseline (median 85 per 106 CD4+ T cells; IQR: 46–180) to the first (median 128 per 106 CD4+ T cells; IQR: 82–353; p = .023) and after the second dose (median 361 per 106 CD4+ T cells; IQR: 146–848; p < .0001). Tenderness (83.0%; 95%CI: 69.2–92.4%) and redness (31.9%; 95%CI: 19.1–47.1%) at injection site were common. One rejection episode within 3 weeks of vaccination was observed. This is the first study demonstrating that RZV was safe and elicited significant humoral and cell-mediated immunity in lung transplant recipients. RZV is a new option for the prevention of shingles in this population. 相似文献
37.
38.
39.
E Arnaud B Couturaud M Revol J M Servant P Banzet 《Annales de chirurgie plastique et esthétique》1999,44(4):357-372
Surgical repair of abdominal wall defects following tumour resection only raises real problems when the nature of the tumour required wide, or even transfixing excision, as in the case of sarcomas or very advanced carcinomas. Superficial repair is performed according to the algorithm of the simplest technique: secondary healing, partial suture, total suture, transplant, or flap (pedicled or free). In the case of transfixing resection, the combination of a biomaterial for reconstruction of the deep plane and a superficial flap is necessary. For very large transfixing defects of the abdomen, a free flap may be required and, in this case, delayed insertion after initial transfer may further reduce the operative risk ("apple turnover" technique). The complications observed in a detailed series of 9 cases operated at Saint-Louis Hospital consisted of one intraoperative cardio-circulatory arrest during second-stage surgery and one late infection at three years. The authors believe that the indications for delayed insertion of a free flap are still very topical in cases in which a very large grafted free flap is necessary in conjunction with a prosthesis. Large abdominal defects after cancer resection can be reconstructed by modern reconstructive surgery. 相似文献
40.